Skip to main content
Clinical Trials/DRKS00027987
DRKS00027987
Recruiting
Phase 4

Prospective, randomized, single-blinded study to test the applicability of extracorporeal shock wave therapy for the treatment of temporomandibular dysfunction. - ESWT_CMD

niversitätsmedizin der Johannes Gutenberg-Universität Mainz0 sites52 target enrollmentJanuary 31, 2022

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
K07.6
Sponsor
niversitätsmedizin der Johannes Gutenberg-Universität Mainz
Enrollment
52
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 31, 2022
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Age \> 18 years
  • \- Myofascial pain with or without mouth opening restriction based on the RDC/TMD (Research Diagnostic Criteria for TMD).
  • \- Uni\- or bilateral temporomandibular joint disorders or disc displacement together with myofascial pain

Exclusion Criteria

  • \- Polyarthritis/arthrosis
  • \- Acute trauma
  • \- TMJ infection
  • \- Surgical therapy or physical therapy, splint therapy, acupuncture within the last 3 months prior to the start of the study
  • \- Current use of pain medication

Outcomes

Primary Outcomes

Not specified

Similar Trials